pembrolizumab
merck
['pembro']
timing of immunotherapy matters. neoadjuvant pembro improves efs over adjuvant administration. presentation of 1801 by #esmo22 
Full Prof Radiation Oncology @gustaveroussy @UnivParisSaclay. EiC https://t.co/ZZv4fFrcCi. Director @SciencesCancer. Adjunct Assoc Prof @MDAndersonNews.